Company / Current Liabilities per Share
BioXcel Therapeutics, Inc. Current Liabilities per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$17.38
FY2025
5-year range
$0.97 / $17.38
FY2022-FY2025
Trend
+46.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.97 to $17.38 over the past 2 years.
Based on SEC 10-K filings.
17.38 in FY2025 with a 3-year CAGR of +145.4%.
Increased from $0.97 to $17.38 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +145.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 46.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -17.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.38 | +46.3% |
| FY2024 | $11.88 | +1126.6% |
| FY2023 | $0.97 | -17.6% |
| FY2022 | $1.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026